Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
Hoffmann-La Roche
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Baptist Health South Florida
Institut Curie
UNICANCER
Suzhou Zanrong Pharma Limited
Dana-Farber Cancer Institute
Seagen Inc.
Cedars-Sinai Medical Center
Sun Yat-sen University
Kadmon Corporation, LLC
US Oncology Research
Second Affiliated Hospital, School of Medicine, Zhejiang University
Dana-Farber Cancer Institute
Novartis
UNC Lineberger Comprehensive Cancer Center
Duke University
University of California, San Francisco
OHSU Knight Cancer Institute
Novartis
Angiochem Inc
BBB-Therapeutics B.V.
GlaxoSmithKline
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
National Cancer Institute (NCI)